Laboratory Corporation of America Holdings
NYSE:LH
Laboratory Corporation of America Holdings
Operating Income
Laboratory Corporation of America Holdings
Operating Income Peer Comparison
Competitive Operating Income Analysis
Latest Figures & CAGR of Competitors
Company | Operating Income | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Laboratory Corporation of America Holdings
NYSE:LH
|
Operating Income
$1.1B
|
CAGR 3-Years
-28%
|
CAGR 5-Years
-4%
|
CAGR 10-Years
1%
|
|
DaVita Inc
NYSE:DVA
|
Operating Income
$1.6B
|
CAGR 3-Years
-2%
|
CAGR 5-Years
1%
|
CAGR 10-Years
-1%
|
|
Chemed Corp
NYSE:CHE
|
Operating Income
$360.9m
|
CAGR 3-Years
3%
|
CAGR 5-Years
8%
|
CAGR 10-Years
10%
|
|
Quest Diagnostics Inc
NYSE:DGX
|
Operating Income
$1.3B
|
CAGR 3-Years
-13%
|
CAGR 5-Years
1%
|
CAGR 10-Years
2%
|
|
CVS Health Corp
NYSE:CVS
|
Operating Income
$15.1B
|
CAGR 3-Years
3%
|
CAGR 5-Years
8%
|
CAGR 10-Years
7%
|
|
Cigna Corp
NYSE:CI
|
Operating Income
$9B
|
CAGR 3-Years
2%
|
CAGR 5-Years
14%
|
CAGR 10-Years
15%
|
See Also
What is Laboratory Corporation of America Holdings's Operating Income?
Operating Income
1.1B
USD
Based on the financial report for Dec 31, 2023, Laboratory Corporation of America Holdings's Operating Income amounts to 1.1B USD.
What is Laboratory Corporation of America Holdings's Operating Income growth rate?
Operating Income CAGR 10Y
1%
Over the last year, the Operating Income growth was -47%. The average annual Operating Income growth rates for Laboratory Corporation of America Holdings have been -28% over the past three years , -4% over the past five years , and 1% over the past ten years .